AMERICAN INTERNATIONAL GROUP, INC. - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,616
-58.3%
10,125
+9.7%
0.00%
Q2 2023$61,492
-64.3%
9,233
+0.0%
0.00%
-100.0%
Q1 2023$172,232
-11.4%
9,230
+2.0%
0.00%0.0%
Q4 2022$194,308
+81.6%
9,046
-0.4%
0.00%0.0%
Q3 2022$107,000
-9.3%
9,079
+1.4%
0.00%0.0%
Q2 2022$118,000
-34.1%
8,951
+4.6%
0.00%0.0%
Q1 2022$179,000
-3.8%
8,561
-6.6%
0.00%0.0%
Q4 2021$186,000
-35.0%
9,163
-2.9%
0.00%
-50.0%
Q3 2021$286,000
+14.9%
9,437
+10.2%
0.00%
+100.0%
Q2 2021$249,000
-22.4%
8,564
+15.0%
0.00%0.0%
Q1 2021$321,000
-6.4%
7,448
+0.3%
0.00%0.0%
Q4 2020$343,000
+12.8%
7,429
+6.0%
0.00%0.0%
Q3 2020$304,000
-11.4%
7,010
+8.3%
0.00%
-50.0%
Q2 2020$343,000
+272.8%
6,473
+57.5%
0.00%
+100.0%
Q1 2020$92,000
+46.0%
4,109
-5.5%
0.00%
Q4 2019$63,000
+133.3%
4,346
+14.2%
0.00%
Q3 2019$27,000
-35.7%
3,807
-0.7%
0.00%
Q2 2019$42,0003,8330.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders